Kirsty Crozier💙 (@kirstycrozier) 's Twitter Profile
Kirsty Crozier💙

@kirstycrozier

Haematology Advanced Clinical Practitioner @GWH | 5th Yr Prof Doc (Nursing) student @oxford_brookes interested in symptom management | views my own.

ID: 2381737066

linkhttps://brookeshls.co1.qualtrics.com/jfe/form/SV_ah0mG3nf5BfidTM calendar_today04-03-2014 07:51:10

5,5K Tweet

1,1K Followers

1,1K Following

Kirsty Crozier💙 (@kirstycrozier) 's Twitter Profile Photo

Would be good to look at the data form this app to see what the symptoms are for CML patients, consider a trial of use to enable a validated tool to use to help manage symptoms

BSH - Haematology (@britsochaem) 's Twitter Profile Photo

There is still time to join our wonderful Education Committee - they are on the look out for two roles; a member with an interest in blood transfusion and an allied health professional member Take a look at more info around the role here: cms-bsh-u9.b-s-h.org.uk/about-us/volun…

There is still time to join our wonderful Education Committee - they are on the look out for two roles;  a member with an interest in blood transfusion and an allied health professional member 

Take a look at more info around the role here:  cms-bsh-u9.b-s-h.org.uk/about-us/volun…
Blood Cancer UK (@bloodcancer_uk) 's Twitter Profile Photo

Today the Government have said millions of people can now search for and sign up to life-changing clinical trials via the NIHR Be Part of Research service on the NHS App. We’re pleased that the Government is looking at ways to increase access to clinical trials in the UK. 1/4

Today the Government have said millions of people can now search for and sign up to life-changing clinical trials via the NIHR Be Part of Research service on the NHS App.

We’re pleased that the Government is looking at ways to increase access to clinical trials in the UK.
1/4
Leukaemia UK (@leukuk) 's Twitter Profile Photo

We attended #EHA2025 where major advances in #leukaemia were shared. 🔬 Menin inhibitors show promise in AML 👴 Age shouldn't limit treatment options 🏠 Push for oral, at-home therapies 🧬 T-ALL: 15 subtypes ID’d for personalised care #BloodCancer #AML #Haematology

We attended #EHA2025 where major advances in #leukaemia were shared.

🔬 Menin inhibitors show promise in AML
👴 Age shouldn't limit treatment options
🏠 Push for oral, at-home therapies
🧬 T-ALL: 15 subtypes ID’d for personalised care

#BloodCancer #AML #Haematology
Lesley Smith 💙 (@lesleylesleys) 's Twitter Profile Photo

“QOL appears both underevaluated & underreported; furthermore, the majority of phase 3 QOL analyses are unadjusted for baseline scores, which lose efficiency & add bias...” 🧐 I mean… All that money, all that patient involvement… But who cares about quality of life hey 🤷

Cathy Harrison 💙 (@cathyah1980) 's Twitter Profile Photo

Reflection of the many roles & responsibilities of the #haemophilia #nurse specialist are highlighted in the management of #AcquiredHaemophilia #ISTH2025

Reflection of the many roles & responsibilities of the #haemophilia #nurse specialist are highlighted in the management of #AcquiredHaemophilia #ISTH2025
MPN Voice (@mpnvoice) 's Twitter Profile Photo

✈️ Planning a trip with an MPN? Don’t miss this essential vlogcast from MPN Voice! Professor Claire Harrison from Guy’s & St Thomas’ Hospital, London, joins Nona for a practical and reassuring chat about travelling with myeloproliferative neoplasms. Whether it’s a weekend away

✈️ Planning a trip with an MPN? Don’t miss this essential vlogcast from MPN Voice!

Professor Claire Harrison from Guy’s & St Thomas’ Hospital, London, joins Nona for a practical and reassuring chat about travelling with myeloproliferative neoplasms. Whether it’s a weekend away
Ally Boyle MBE (@fireboyle) 's Twitter Profile Photo

Blood Cancer UK we are very excited to launch our new research strategy…because we know research will give us our best chance of #BeatingBloodCancer Very proud to make opening comments alongside the amazing Helen Rowntree bloodcancer.org.uk/research/resea…

Beth Psaila (@beth_psaila) 's Twitter Profile Photo

MPN community (patients/families) - do join us with MPN voice tomorrow if you are interested to hear updates on all the exciting data presented at the recent European Haematology Congress MPN Voice MPN Research Foundation European Hematology Association mpnvoice.org.uk/news/mpn-voice…

Blood Cancer UK Research (@bloodcancer_res) 's Twitter Profile Photo

We have 2 exciting roles in our team: Research Engagement Officer (p/t, hybrid £31,000 - £35,000 / year) Research Grants Officer (hybrid, £35,000 - £37,000 / year) More info here 👉🏻 shorturl.at/s8jYf Please share and get in touch if you’re interested ☺️

We have 2 exciting roles in our team:

Research Engagement Officer (p/t, hybrid 
£31,000 - £35,000 / year)

Research Grants Officer (hybrid, £35,000 - £37,000 / year)

More info here 👉🏻 shorturl.at/s8jYf

Please share and get in touch if you’re interested ☺️
Blood Cancer UK Research (@bloodcancer_res) 's Twitter Profile Photo

🚨 1-month reminder Our clinical improvement programme awards grants up to £25k for projects to improve access to and awareness of blood cancer clinical trials. 🗓 Deadline: 4th August 2025 🔗 Apply now: bloodcancer.org.uk/cip1

Journal of Advanced Nursing (@jadvnursing) 's Twitter Profile Photo

What helps or hinders nurses to lead funded research projects? A survey of UK nurse lead‐investigators - onlinelibrary.wiley.com/doi/10.1111/ja…

Richard Buka 💙 (@richardbuka) 's Twitter Profile Photo

Importantly, we found that by the time these patients were seen in clinic, the haematocrit was already falling and had often reduced below diagnostic threshold by 12 months from first clinic assessment.

Importantly, we found that by the time these patients were seen in clinic, the haematocrit was already falling and had often reduced below diagnostic threshold by 12 months from first clinic assessment.
Richard Buka 💙 (@richardbuka) 's Twitter Profile Photo

Over median 6.2 y follow-up, rate of new VTE: 2.9% and new arterial thrombosis: 7.3%. Mortality rate: 15% The only predictor of thrombosis was prior VTE. Neither venesection nor persistence of polycythaemia affected either thrombosis or mortality

Over median 6.2 y follow-up, rate of new VTE: 2.9% and new arterial thrombosis: 7.3%. Mortality rate: 15%
The only predictor of thrombosis was prior VTE.
Neither venesection nor persistence of polycythaemia affected either thrombosis or mortality
Kirsty Crozier💙 (@kirstycrozier) 's Twitter Profile Photo

Week 2 at the MRC WIMM Completely clueless, imposter syndrome on 🔝level…BUT meeting with some of the researchers and finding out about their studies/interests….WOW!! My wee mind is blown! So super interesting! Excited to find out more 😄 Beth Psaila Adam Mead

Week 2 at the <a href="/MRC_WIMM/">MRC WIMM</a> 
Completely clueless, imposter syndrome on 🔝level…BUT meeting with some of the researchers and finding out about their studies/interests….WOW!! My wee mind is blown! So super interesting! Excited to find out more 😄
<a href="/beth_psaila/">Beth Psaila</a> <a href="/AdamMead_Oxford/">Adam Mead</a>